Department of Dermatology, University Hospital of Zurich, Switzerland
Zurich, Canton of Zurich, CH-8091, Switzerland
NCT Number: NCT02621632
The study intends to investigate a novel compression system termed Socknleg composed of an understocking covering the foot with three added stockings extending from the ankle to the knee without covering the foot. The novel Socknleg system is compared to a standard class III compression stocking.
Looking for future studies?
Notify MeInterventional
Phase 4
Zurich, Canton of Zurich, CH-8091, Switzerland
The investigator tests a novel compression system termed Socknleg in 20 healthy individuals and 20 patients with chronic venous disease. Socknleg is composed of an understocking covering the foot with three added stockings extending from the ankle to the knee without covering the foot. The novel Socknleg system is compared to a standard class III compression stocking. Outcome measures are successful donning and the comparison of interface pressure measured on the level of the ankle.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
To done a novel compression system.
Time frame: Successful donning has to be completed within 5 minutes.
Ability to fully done the investigated compression devices.
Time frame: Interface pressure is measured within 5 minutes of complete donning of the stocking.
Interface pressure of the compression systems is measured at level cB1 (transition of the Achilles tendon to the calf muscle) in mmHg by a pressure measuring device termed Picopress® . Interface pressure is compared between the novel compression system and the comparator, a class III compression stocking.
University of Zurich
Other
Acronym: Socknleg
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07616115
Cardiovascular Diseases, Saphenous Vein
São Paulo, Brazil
View Trial DetailsNCT06438133
Cardiovascular Diseases, Compression; Vein
Bispebjerg, Capital Region, Denmark
View Trial DetailsNCT02061254
Cardiovascular Diseases, Fibrosis
Tours, France
View Trial DetailsNCT01558024
Cardiovascular Diseases, Vascular Diseases
Montpellier, France
View Trial Details